Caroline E. McCoach

5.5k total citations
56 papers, 1.5k citations indexed

About

Caroline E. McCoach is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Caroline E. McCoach has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Caroline E. McCoach's work include Lung Cancer Treatments and Mutations (38 papers), Colorectal Cancer Treatments and Studies (14 papers) and Lung Cancer Research Studies (12 papers). Caroline E. McCoach is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Colorectal Cancer Treatments and Studies (14 papers) and Lung Cancer Research Studies (12 papers). Caroline E. McCoach collaborates with scholars based in United States, Singapore and France. Caroline E. McCoach's co-authors include Robert C. Doebele, D. Ross Camidge, Anh T. Le, John R. Laird, Satinder Singh, Gregory G. Westin, Ehrin J. Armstrong, Ezra A. Amsterdam, David R. Anderson and Khung Keong Yeo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Caroline E. McCoach

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline E. McCoach United States	18	1.0k	757	413	383	290	56	1.5k
Takeru Wakatsuki Japan	21	714 0.7×	1.1k 1.5×	356 0.9×	319 0.8×	531 1.8×	159	1.8k
Seung Eun Lee South Korea	19	545 0.5×	475 0.6×	310 0.8×	239 0.6×	186 0.6×	46	1.0k
Kumari Chandrawansa United States	13	1.6k 1.6×	1.4k 1.8×	470 1.1×	230 0.6×	695 2.4×	20	2.4k
Yihebali Chi China	16	817 0.8×	1.5k 2.0×	308 0.7×	172 0.4×	378 1.3×	67	2.0k
Consuelo Buttigliero Italy	23	1.0k 1.0×	692 0.9×	411 1.0×	397 1.0×	294 1.0×	91	1.7k
Clive Morris United Kingdom	14	468 0.4×	629 0.8×	735 1.8×	249 0.7×	130 0.4×	38	1.4k
Zhongsheng Tong China	20	754 0.7×	1.2k 1.6×	324 0.8×	372 1.0×	79 0.3×	105	1.7k
Gaetano Aurilio Italy	18	730 0.7×	725 1.0×	318 0.8×	529 1.4×	201 0.7×	65	1.4k
Edoardo Francini Italy	20	632 0.6×	554 0.7×	210 0.5×	291 0.8×	112 0.4×	73	1.2k
Jiuda Zhao China	17	573 0.5×	764 1.0×	337 0.8×	274 0.7×	214 0.7×	88	1.3k

Countries citing papers authored by Caroline E. McCoach

Since Specialization

Citations

This map shows the geographic impact of Caroline E. McCoach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. McCoach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. McCoach more than expected).

Fields of papers citing papers by Caroline E. McCoach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline E. McCoach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. McCoach. The network helps show where Caroline E. McCoach may publish in the future.

Co-authorship network of co-authors of Caroline E. McCoach

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline E. McCoach. A scholar is included among the top collaborators of Caroline E. McCoach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline E. McCoach. Caroline E. McCoach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marmarelis, Melina E., Caroline E. McCoach, Geoffrey Liu, et al.. (2023). Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 41(16_suppl). 9116–9116.

Ali, Moiez, Min Lu, Ryan S. Soderquist, et al.. (2022). Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. Science Translational Medicine. 14(638). eabc7480–eabc7480. 29 indexed citations

McCoach, Caroline E., Christian Rolfo, Alexander Drilon, et al.. (2022). Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001. Journal of Thoracic Oncology. 17(6). 768–778. 27 indexed citations

Aredo, Jacqueline V., Jessica A. Hellyer, Joel W. Neal, et al.. (2021). MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy. Journal of Thoracic Oncology. 16(1). S15–S15. 1 indexed citations

Aredo, Jacqueline V., Isa Mambetsariev, Jessica A. Hellyer, et al.. (2021). Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy. Journal of Thoracic Oncology. 16(6). 1030–1041. 86 indexed citations

Gautschi, Oliver, Alexander Drilon, Daniel S.W. Tan, et al.. (2020). 1290P Efficacy and safety with selpercatinib by last prior systemic therapy received in patients (Pts) with RET fusion + non-small cell lung cancer (NSCLC). Annals of Oncology. 31. S835–S835. 1 indexed citations

McCoach, Caroline E., Benjamin Besse, Keiko Goto, et al.. (2020). 1291P Hypersensitivity reactions (HR) to selpercatinib in RET fusion+ non-small cell lung cancer (NSCLC) patients (pts) following immune checkpoint inhibition (CPI). Annals of Oncology. 31. S835–S836. 6 indexed citations

Velázquez, Ana I. & Caroline E. McCoach. (2020). Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer. Journal of Thoracic Disease. 12(5). 2896–2909. 5 indexed citations

Linehan, W. Marston, Stephen V. Liu, Caroline E. McCoach, et al.. (2020). Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Annals of Oncology. 31(12). 1725–1733. 161 indexed citations

10.

Rotow, Julia, Anatoly Urisman, Caroline E. McCoach, et al.. (2019). P1.14-58 A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S578–S578. 6 indexed citations

11.

McCoach, Caroline E., Anh T. Le, Katherine Gowan, et al.. (2018). Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non–small Cell Lung Cancer. Clinical Cancer Research. 24(14). 3334–3347. 179 indexed citations

12.

McCoach, Caroline E., Collin M. Blakely, Kimberly C. Banks, et al.. (2018). Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(12). 2758–2770. 114 indexed citations

13.

Neel, Dana S., Victor Olivas, Manasi K. Mayekar, et al.. (2018). Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins. Cancer Research. 79(3). 546–556. 63 indexed citations

14.

McCoach, Caroline E., Gideon M. Blumenthal, Adrian Myers, et al.. (2017). Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy. Annals of Oncology. 28(11). 2707–2714. 63 indexed citations

15.

McCoach, Caroline E., Trever G. Bivona, Collin M. Blakely, & Robert C. Doebele. (2016). Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non–Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance. Clinical Lung Cancer. 17(5). 466–469. 16 indexed citations

16.

McCoach, Caroline E., et al.. (2016). Osimertinib, a third-generation tyrosine kinase inhibitor targetingnon-small cell lung cancer with EGFR T790M mutations. Drugs of today. 52(10). 561–561. 9 indexed citations

17.

McCoach, Caroline E., Eamon M. Berge, Xian Lu, Anna E. Barón, & D. Ross Camidge. (2015). A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry. Journal of Thoracic Oncology. 11(3). 407–413. 43 indexed citations

18.

McCoach, Caroline E. & Robert C. Doebele. (2014). The Minority Report: Targeting the Rare Oncogenes in NSCLC. Current Treatment Options in Oncology. 15(4). 644–657. 13 indexed citations

19.

Faddah, Dina A., Eric Ganko, Caroline E. McCoach, et al.. (2009). Systematic Identification of Balanced Transposition Polymorphisms in Saccharomyces cerevisiae. PLoS Genetics. 5(6). e1000502–e1000502. 4 indexed citations

20.

Flaig, Thomas W., Lih‐Jen Su, Caroline E. McCoach, et al.. (2009). Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose‐ and sequence‐dependent manner. British Journal of Urology. 103(12). 1729–1737. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact